SOPHIRIS BIO INC.
DelistedCIK 1563855fmd_1ZCQ4VNBBK70F6830MDT825KVAManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 11, 2002 to Sep 30, 2019, 41 periods
| Line item | FY2009 | FY2010 | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 | FY2017 | FY2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Research and development | – | – | 9 | 14 | 10 | 25 | 10 | 4 | 6 | 11 |
| Total operating expenses | – | – | 13 | 19 | 15 | 30 | 13 | 10 | 12 | 15 |
| Interest expense | – | – | 1 | 2 | 1 | 1 | 1 | 0 | 0 | 1 |
| Other non-operating income (expense) | – | – | (1) | (2) | (1) | (1) | (1) | (1) | 3 | 8 |
| Income before taxes | – | – | (14) | (21) | (11) | (31) | (14) | (11) | (9) | (7) |
| Income tax expense | – | – | – | – | 1 | – | – | – | – | – |
| Net income from continuing operations | – | – | – | – | (11) | – | – | – | – | – |
| Net income | (7) | (4) | (14) | (21) | (11) | (31) | (14) | (11) | (9) | (7) |